Regulatory Affairs Senior Director - Global Regulatory Leader - Oncology
Ladders · United States · 2 mo ago
RemoteRemoteLegal$215k–$291k/yrFull-time
Location: Remote – US-based candidates only, no visa sponsorship available
Compensation: $215,204 – $291,159 annually
About the role
This role will provide business-aligned guidance focused on governance, compliance, and operational risk management. You will partner with leaders, compliance stakeholders, and cross-functional teams to translate complex issues into practical recommendations. The position offers the opportunity to strengthen responsible execution, improve decision-making, and support sustainable growth within a life sciences environment.
Responsibilities
- Develop and execute global regulatory product strategies for complex, late-stage assets
- Lead Global Regulatory Teams (GRTs) and advise on regulatory objectives
- Create comprehensive Global Regulatory Strategic Plans from cross-functional input
- Direct interactions and planning for global regulatory filings, including marketing applications
- Monitor global regulations and advise teams on relevant changes and implications
- Communicate regulatory strategies and risks to ensure understanding of success probabilities
- Guide regulatory processes and improvements at the organizational level
Qualifications
- Doctorate degree with 5 years of regulatory experience in biotech or science, or a Master's degree with 9 years, or a Bachelor's degree with 11 years of relevant experience
- Minimum of 5 years in a management or leadership role, directing teams or projects
- Experience in late-stage regulatory strategy for high complexity programs
- Demonstrated oncology expertise is a plus
- Strong abilities in team leadership, communication, and negotiation
Benefits
- Comprehensive employee benefits package, including medical, dental, and vision coverage
- Retirement and Savings Plan with company contributions
- Flexible work models where applicable
- Award-winning time-off plans to promote work-life balance
- Discretionary annual bonus program and stock-based long-term incentives